Ratings Lowered On Class F, G, And H Notes In Titan Europe 2006-2's CMBS Transaction Nov 10

  • ID: 1782817
  • November 2010
  • Region: Europe
  • Standard & Poors
1 of 3


  • Titan Europe 2006-2 PLC
  • MORE

OVERVIEW The class H notes suffered a second consecutive interest shortfall on the October 2010 note interest payment date. The interest shortfalls follow a nonpayment of interest under the Velvet loan. We have lowered the ratings on the class F, G, and H notes. All other ratings remain unchanged. Titan Europe 2006-2 is a CMBS transaction that closed in 2006 and comprises four loans secured on multifamily housing properties in Germany. LONDON (Standard & Poor's) Nov. 10, 2010--Standard & Poor's Ratings Services today lowered its credit ratings on Titan Europe 2006-2 PLC's class F, G, and H notes (see list below). These rating actions follow a second consecutive shortfall in interest payments on the class H notes and our expectation...

Companies mentioned in this report are:
- Titan Europe 2006-2 PLC

Action: Downgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Titan Europe 2006-2 PLC

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.